Michael S. Leibowitz
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 10
- CAR-T cell therapy research 4
- Peptidase Inhibition and Analysis 3
- Cancer Immunotherapy and Biomarkers 2
- Cytokine Signaling Pathways and Interactions 2
-
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 3
- Co-authors
- Robert Louis Ferris (6 shared papers)Pedro A. Andrade Filho (2 shared papers)Soldano Ferrone (2 shared papers)Steven M Albelda (3 shared papers)Robert H. Vonderheide (2 shared papers)Jing Sun (2 shared papers)Maria Liousia (2 shared papers)Astero Klampatsa (2 shared papers)
- Journals
- Cancer Research (2 papers)Clinical Cancer Research (2 papers)Current Oncology Reports (1 paper)American Journal of Physiology-Lung Cellular and Molecular Physiology (1 paper)Cell Reports (1 paper)
- Partner nations
- United StatesSlovakiaUnited Kingdom
In The Last Decade
Michael S. Leibowitz
17 papers receiving 1.4k citations
Michael S. Leibowitz's Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 661
- Immunology 481
- Cancer Research 179
- Cardiology and Cardiovascular Medicine 220
- Molecular Biology 475
Countries citing papers authored by Michael S. Leibowitz
This map shows the geographic impact of Michael S. Leibowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Leibowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Leibowitz more than expected).
Fields of papers citing papers by Michael S. Leibowitz
This network shows the impact of papers produced by Michael S. Leibowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Leibowitz. The network helps show where Michael S. Leibowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael S. Leibowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting cardiac fibrosis with engineered T cells Hit paper breakdown → | 2019 | 625 |
| 2 | 2020 | 279 | |
| 3 | 2005 | 103 | |
| 4 | 2011 | 89 | |
| 5 | 2007 | 88 | |
| 6 | 2013 | 67 | |
| 7 | 2020 | 48 | |
| 8 | 2008 | 46 | |
| 9 | 2019 | 33 | |
| 10 | 2007 | 27 | |
| 11 | 2008 | 24 | |
| 12 | 2008 | 15 | |
| 13 | 2009 | 8 | |
| 14 | 2019 | 8 | |
| 15 | 2018 | 5 | |
| 16 | 2022 | 3 | |
| 17 | 2024 | 2 |
About Michael S. Leibowitz
Michael S. Leibowitz is a scholar working on Oncology, Immunology, Cancer Research, Biochemistry and Physiology, having authored 17 papers that have together received 1.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (4 papers), Peptidase Inhibition and Analysis (3 papers), Immune Cell Function and Interaction (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer Genomics and Diagnostics (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Oncology (661 citations), Immunology (481 citations), Cancer Research (179 citations), Cardiology and Cardiovascular Medicine (220 citations) and Molecular Biology (475 citations). Michael S. Leibowitz has collaborated with scholars based in United States, Slovakia and United Kingdom. Frequent co-authors include Robert Louis Ferris, Pedro A. Andrade Filho, Soldano Ferrone, Steven M Albelda, Robert H. Vonderheide, Jing Sun, Maria Liousia, Astero Klampatsa, Peter A. DeLong and Sajjad Ahmad. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Current Oncology Reports, American Journal of Physiology-Lung Cellular and Molecular Physiology and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.